Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says - In the first ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...